Preventing prolonged post-operative ileus in gastric cancer patients undergoing gastrectomy and intra-peritoneal chemotherapy

Table 1 Clinicopathological characteristics of patients in three groups

	Group A(n = 16)	Group B(n = 16)	Group C(n = 16)	P
Sex (M/F)	11/5	12/4	10/6	NS
Age (yr)	56.8±13.2	57.5±11.7	67.5±17.7	0.048
Sub-total/total gastrectomy	11/5	10/6	10/6	NS
Operation time (min)	272±60	312±69	259±43	NS
Blood loss (mL)	216±106	235±92	196±137	NS
Meperidine use (mg/d)	83.3±21.6	91.4±31.2	79.3±15.9	NS
Primary tumor1				NS
pT3	14	13	14
pT4	2	3	2
Stage2				NS
II	4	4	3
IIIa	4	3	4
IIIb	5	6	6
IV	3	3	3

Gender was assessed by χ²-test, others were assessed by t-test. Significant difference in age (P = 0.048) between group C and groups A and B.

¹T classification according to the Japanese Classification of Gastric Carcinoma (22).

²Staging classification according to the 1997 TNM staging system. NS: not significant. All patients had received R0 gastrectomy with D2 lymph node dissection.